Anti-Thyroid Peroxidase Antibody in Vitiligo: A Prevalence Study

Table 1

Sample characteristics of study participants.

Sl. number	Characteristic variable	Total ( = 100)
1	Number of male, female participants	41, 59
2	Age^# (years)	29.49 ± 15.00; 28.00
3	Reported age at onset of vitiligo^# (years)	24.80 ± 15.66; 21.25
4	Duration since first lesion of vitiligo^# (years)	4.64 ± 6.05; 2.00
5	Positive history of vitiligo in family (%)	13.00
6	Positive history of precipitating factors (%)	8.00
7	Stable vitiligo [Vitiligo Disease Activity (VIDA) Score ≤ 0]	15
8	Type of vitiligo (segmental; nonsegmental) (%)	4.00; 96.00
9	Vitiligo Assessment Severity Index (VASI) <1.00 (%)	22.00
10	Variants of vitiligo (quadrichrome and trichrome) (%)	12.00
11	Koebner’s phenomenon present (%)	05.00
12	Leukotrichia present (%)	14.00
13	Associated dermatological disorders (%)	5.00
14	Associated systemic disorder (%)	4.00^$
15	Associated nonthyroid autoimmune disorder (%)	2.00^@

Mean ± standard deviation; median; ^$all reported diabetes mellitus; one reported coexistent bronchial asthma; ^@one participant reported alopecia areata and duodenitis/gastritis with pernicious anaemia.